Company Profile
Public information reviewed
Regeneron Pharmaceuticals
Canonical company identity and public leadership record.
USNASDAQ: REGN
- Public sources
- 2 reviewed
- Published leadership records
- 19
- Last reviewed
- Sep 21, 2026
Agent View
Machine representations
Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.
Markdown
https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc.mdRegeneron Pharmaceuticals
Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
Record
| Field | Value |
|---|---|
| Representation | alpha-profile-markdown-v3 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Canonical entity | alpha:company:bee12477-9858-4107-8779-4e9347bf356a |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/regeneron-pharmaceuticals-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 28 |
| Claims under review | 1 |
| Evidence records | 7 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-09-21T04:45:16.68769+00:00 |
| Last reviewed | 2026-09-21T04:45:16.68769+00:00 |
Identity
- Legal name: REGENERON PHARMACEUTICALS, INC.
- Display name: Regeneron Pharmaceuticals
Leadership
- Anita J. Ryan: Independent Director. Valid from: 2003-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- Bonnie L. Bassler: Independent Director. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- Christine A. Poon: Lead Independent Director. Valid from: 2010-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- Craig B. Thompson: Director. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- David P. Schenkein: Independent Director. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- George D. Yancopoulos: Director. Valid from: 2001-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- George L. Sing: Independent Director. Valid from: 1988-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- Huda Y. Zoghbi: Independent Director. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- Joseph L. Goldstein: Independent Director. Valid from: 1991-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- Kathryn Guarini: Independent Director. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- Leonard S. Schleifer: Director. Valid from: 1988-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- Michael S. Brown: Independent Director. Valid from: 1991-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- N. Anthony Coles: Independent Director. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3.
- Andrew J. Murphy, Ph.D.: Executive Vice President, Co-Chief Scientific Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:4.
- Christopher Fenimore: Executive Vice President, Finance and Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:4.
- Daniel P. Van Plew: Executive Vice President and General Manager, Industrial Operations and Product Supply. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:4.
- George D. Yancopoulos, M.D., Ph.D.: Board co-Chair, President and Chief Scientific Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:4.
- Leonard S. Schleifer: Chief Executive Officer. Valid from: 2026-02-04. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:5.
- Leonard S. Schleifer, M.D., Ph.D.: Board co-Chair, President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:4.
Roles
- PUBLISHED
Governance
- NOT_ASSERTED
Board committees
- PUBLISHED
Financials
- NOT_ASSERTED
Workforce
- NOT_ASSERTED
Market and index context
- S&P 500 (SPX). Valid from: 2013-05-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:6.
- Nasdaq-100 (NDX). Valid from: 2026-09-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:7.
Legal Name
- REGENERON PHARMACEUTICALS, INC.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:1.
Headquarters
- US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.
Entity Status
- Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:1.
Official Website
- https://www.regeneron.com. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:2.
Published Fact
- US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:1.
- NY. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:1.
- Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:1.
- https://www.regeneron.com. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:2.
Coverage states
| Field | Value |
|---|---|
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
Public sources
- alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:1: Alpha canonical company public projection.
- alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:2: REGENERON PHARMACEUTICALS, INC. Form 10-K (filed 2026-02-04).
- alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:3: Regeneron Pharmaceuticals, Inc. DEF 14A 2026-04-24.
- alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:4: SEC DEF 14A 0001308179-26-000340.
- alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:5: REGN 10-K executive officers.
- alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:6: S&P 500.
- alpha:evidence:company:bee12477-9858-4107-8779-4e9347bf356a:7: Nasdaq-100.
Rights
| Field | Value |
|---|---|
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
Alternate representations
- Canonical profile
- Public Markdown
- Public JSON
- JSON-LD
- MCP resource:
alpha://companies/regeneron-pharmaceuticals-incat https://mcp.alpha.ac/mcp